LasagnaL.: Editorial: Placebos and controlled trials under attack. Eur. J. Clin. Pharmacol.15:373–374, 1979.
2.
TweeddaleM.G.OgilvieR.I.RudeyJ.: Antihypertensive and biochemical effects of chlorthalidone. Clin. Pharmacol. Ther.22:519–527, 1977.
3.
MatersonB.J.OsterJ.R.MichaelU.F.BoltonS.M.BurtonZ.C.StambaughJ.E.MorledgeJ.: Dose response to chlorthalidone in patients with mild hypertension. Clin. Pharmacol. Ther.24:192–198, 1978.
4.
OnoyamaK.HirakataH.IsekiK.FujimiS.OmaeT.KobayashiM.KawaharaY.: Blood concentration and urinary excretion of captopril (SQ 14,225) in patients with chronic renal failure. Hypertension3:456–459, 1981.
5.
AmeryW.DonyJ.: A clinical trial design avoiding undue placebo treatment. J. Clin. Pharmacol.15:674–679, 1975.